2-[7-[(3-Aminophenyl)methyl]-3-methyl-2,6-dioxopurin-8-yl]sulfanyl-2-ethylbutanoic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: 2-[7-[(3-Aminophenyl)methyl]-3-methyl-2,6-dioxopurin-8-yl]sulfanyl-2-ethylbutanoic acid
• 英文别名: 2-[7-[(3-aminophenyl)methyl]-3-methyl-2,6-dioxopurin-8-yl]sulfanyl-2-ethylbutanoic acid
• 化学式: C₁₉H₂₃N₅O₄S
• 分子量: 417.5
• InChiKey: AXHBIIOHUVLGRL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  29
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.37
• 拓扑面积：
  156
• 氢给体数：
  3
• 氢受体数：
  7

文献信息

• METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA
  申请人：Gallagher Michela

  公开号：US20140206667A1

  公开（公告）日：2014-07-24

  The invention relates to methods and compositions for treating schizophrenia or bipolar disorder (in particular, mania) by using a combination of a synaptic vesicle protein 2A (SV2A) inhibitor and an antipsychotic or their pharmaceutically acceptable salts, hydrates, solvates, polymorphs thereof. In some embodiments, the methods and the compositions are for treating one or more positive and/or negative symptoms, as well as cognitive impairment, associated with schizophrenia or bipolar disorder (in particular, mania).